5-methoxy-methylindoleacetic acid and Metastase

5-methoxy-methylindoleacetic acid has been researched along with Metastase in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adeniji, AO; Byrns, MC; Chen, M; Christianson, DW; Jin, Y; Liedtke, AJ; Marnett, LJ; Penning, TM	1

Other Studies

1 other study(ies) available for 5-methoxy-methylindoleacetic acid and Metastase

Article	Year
Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer. Journal of medicinal chemistry, 2013, Mar-28, Volume: 56, Issue:6 Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Catalytic Domain; Enzyme Inhibitors; Genes, Reporter; HeLa Cells; Humans; Hydroxyprostaglandin Dehydrogenases; Indomethacin; Male; Models, Molecular; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Substrate Specificity	2013

Article

Year

Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.

Journal of medicinal chemistry, 2013, Mar-28, Volume: 56, Issue:6

Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Catalytic Domain; Enzyme Inhibitors; Genes, Reporter; HeLa Cells; Humans; Hydroxyprostaglandin Dehydrogenases; Indomethacin; Male; Models, Molecular; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Substrate Specificity

2013